Starling Oncology, Inc. (STLN)

Starling Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	36.9	33.57	49.67	33.49	14.01	114.3
Short-Term Investments	-	-	-	49.37	59.8	-
Cash & Short-Term Investments	36.9	33.57	49.67	82.86	73.81	114.3
Cash Growth	33.40%	-32.42%	-40.05%	12.26%	-35.43%	1805.62%
Accounts Receivable	60.68	59	48.34	42.36	39.82	20.01
Other Receivables	0.13	0.32	0.35	0.55	0.62	1.24
Receivables	60.8	59.32	48.68	42.91	40.43	21.24
Inventory	36.63	16.88	10.04	13.68	9.26	6.44
Prepaid Expenses	3.36	2.99	4.03	4.05	6.92	11.2
Restricted Cash	-	-	-	-	-	0.88
Total Current Assets	137.69	112.75	112.42	143.49	130.42	154.06
Property, Plant & Equipment	32.57	33.06	37.67	40.05	33.04	4.19
Long-Term Investments	-	-	-	-	58.35	-
Goodwill	7.23	7.23	7.23	7.23	21.42	26.63
Other Intangible Assets	8.87	11.02	14.81	17.9	17.96	18.25
Other Long-Term Assets	1.42	0.61	0.59	0.56	0.48	0.32
Total Assets	187.77	164.66	172.72	209.24	261.67	203.44

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	82.09	43.17	24.32	14.43	9.37	15.56
Accrued Expenses	22.65	11.5	9.28	10.7	9.42	8.33
Short-Term Debt	5	0.79	0.77	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.18
Current Portion of Leases	7.31	7.19	6.8	6.36	5.5	-
Current Income Taxes Payable	-	-	-	-	0.26	0.13
Current Unearned Revenue	-	2.28	2.35	1.09	1.14	0.26
Other Current Liabilities	6.66	6.02	8.69	2.21	4.04	5.33
Total Current Liabilities	123.7	70.96	52.22	34.79	29.72	29.8
Long-Term Debt	72.52	77.4	93.13	86.83	80.62	-
Long-Term Leases	17.95	19.16	23.22	26.49	22.06	-
Long-Term Deferred Tax Liabilities	-	-	0.03	0.03	0.11	0.37
Other Long-Term Liabilities	10.96	12.86	0.53	4.08	5.98	69.11
Total Liabilities	225.13	180.38	169.13	152.22	138.49	99.28

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	263.1	256.71	215.41	204.19	186.25	167.39
Retained Earnings	-299.45	-271.42	-210.81	-146.15	-63.08	-63.23
Treasury Stock	-1.02	-1.02	-1.02	-1.02	-	-
Total Common Equity	-37.36	-15.72	3.59	57.03	123.18	104.16
Shareholders' Equity	-37.36	-15.72	3.59	57.03	123.18	104.16
Total Liabilities & Equity	187.77	164.66	172.72	209.24	261.67	203.44

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	102.77	104.55	123.92	119.68	108.18	0.18
Net Cash (Debt)	-65.88	-70.98	-74.25	-36.82	-34.37	114.12
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.64	-0.77	-0.99	-0.50	-0.43	1.72
Filing Date Shares Outstanding	101.99	98.84	75.75	74.31	74.55	73.25
Total Common Shares Outstanding	101.99	98.86	75.74	74.15	73.27	73.25
Working Capital	13.99	41.79	60.2	108.71	100.7	124.26
Book Value Per Share	-0.37	-0.16	0.05	0.77	1.68	1.42
Tangible Book Value	-53.45	-33.97	-18.45	31.89	83.8	59.29
Tangible Book Value Per Share	-0.52	-0.34	-0.24	0.43	1.14	0.81
Machinery	9.1	7.42	6.05	5.84	3.88	2.11
Construction In Progress	1.16	1.14	0.11	1.8	1.14	0.52
Leasehold Improvements	13.28	12.85	12.5	9.21	6.66	3.39

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error